Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula De Vos

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Atherosclerosis|November 22, 2008
Vaccination against TIE2 reduces atherosclerosisArnaud D Hauer, Kim L L Habets, Eva J A van Wanrooij, et al.
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
Journal of Lipid Research|March 18, 2005
Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J miceRuud Out, Menno Hoekstra, Saskia C A de Jager, et al.
Cardiovascular Research|October 13, 2009
Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient miceKim L L Habets, Gijs H M van Puijvelde, Leonie M van Duivenvoorde, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 2007
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient miceEva J A van Wanrooij, Saskia C A de Jager, Thomas van Es, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 30, 2007
Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosisArnaud D Hauer, Gijs H M van Puijvelde, Niels Peterse, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Atherosclerosis|November 22, 2008
Vaccination against TIE2 reduces atherosclerosisArnaud D Hauer, Kim L L Habets, Eva J A van Wanrooij, et al.
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
Journal of Lipid Research|March 18, 2005
Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J miceRuud Out, Menno Hoekstra, Saskia C A de Jager, et al.
Cardiovascular Research|October 13, 2009
Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient miceKim L L Habets, Gijs H M van Puijvelde, Leonie M van Duivenvoorde, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 2007
CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient miceEva J A van Wanrooij, Saskia C A de Jager, Thomas van Es, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 30, 2007
Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosisArnaud D Hauer, Gijs H M van Puijvelde, Niels Peterse, et al.
Pageof 2